Skip to content

Clinical trials

Lymphoma, Mantle-Cell trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Country / region: Germany Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20033
20045
20054
20061
20084
20093
20105
20112
20121
20135
20141
20154
20162
20174
20182
20193
20201
20213
20223
20233
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Active, not recruiting9
Recruiting8
Unknown status8
Terminated7
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene7
European Organisation for Research and Treatment of Cancer - EORTC6
Fred Hutchinson Cancer Center6
BeOne Medicines4
German High-Grade Non-Hodgkin's Lymphoma Study Group4
AstraZeneca3
Eli Lilly and Company3
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
European Mantle Cell Lymphoma Network2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell74
Lymphoma, Non-Hodgkin35
Lymphoma, Follicular34
Lymphoma, Large B-Cell, Diffuse29
Leukemia, Lymphocytic, Chronic, B-Cell25
Lymphoma, B-Cell, Marginal Zone24
Lymphoma20
Waldenstrom Macroglobulinemia17
Burkitt Lymphoma16
Precursor Cell Lymphoblastic Leukemia-Lymphoma15

Trials

Showing 51 to 74 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.